Cargando…
TSH suppressive therapy and bone
Thyroid hormones stimulate bone turnover in adults by increasing osteoclastic bone resorption. TSH suppressive therapy is usually applied in patients with differentiated thyroid cancer (DTC) to improve the disease outcome. Over the last decades several authors have closely monitored the potential ha...
Autores principales: | Brancatella, Alessandro, Marcocci, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424360/ https://www.ncbi.nlm.nih.gov/pubmed/32567550 http://dx.doi.org/10.1530/EC-20-0167 |
Ejemplares similares
-
Calcifediol Rather Than Cholecalciferol for a Patient Submitted to Malabsortive Bariatric Surgery: A Case Report
por: Brancatella, Alessandro, et al.
Publicado: (2017) -
TSH-Suppressive Therapy: A Thorny Issue
por: Baldini, Itala Marina, et al.
Publicado: (2017) -
Trabecular bone deterioration in differentiated thyroid cancer: Impact of long‐term TSH suppressive therapy
por: Hawkins Carranza, Federico, et al.
Publicado: (2020) -
FSH and TSH in the Regulation of Bone Mass: The Pituitary/Immune/Bone Axis
por: Colaianni, Graziana, et al.
Publicado: (2013) -
Factors Predicting Time to TSH Normalization and Persistence of TSH Suppression After Total Thyroidectomy for Graves' Disease
por: Paragliola, Rosa Maria, et al.
Publicado: (2019)